RISE1159
|
GAC |
Neolithic |
Poland |
F |
-2880 |
-2776 |
T2b |
bam
|
2.80
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
-
4440A (MT-TM): Mitochondrial myopathy (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE1162
|
GAC |
Neolithic |
Poland |
M |
-2880 |
-2776 |
K1a1b1e |
bam
|
3.00
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
114T (MT-CR): BD-associated (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
4440A (MT-TM): Mitochondrial myopathy (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE1166
|
GAC |
Neolithic |
Poland |
F |
-2880 |
-2776 |
J1c3f |
bam
|
3.00
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12477C (MT-ND5): possible HCM susceptibility (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
-
4440A (MT-TM): Mitochondrial myopathy (Reported)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
RISE1167
|
GAC |
Neolithic |
Poland |
F |
-2880 |
-2776 |
J1c3f |
bam
|
2.50
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12477C (MT-ND5): possible HCM susceptibility (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
RISE1170
|
GAC |
Neolithic |
Poland |
F |
-2880 |
-2776 |
K1a1b1e |
bam
|
3.70
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
114T (MT-CR): BD-associated (Reported)
-
1095C (MT-RNR1): SNHL (Unclear)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
4437T (MT-TM): Hypotonia / seizure / muscle weakness / lactic acidosis / hearing loss (Reported)
-
5703A (MT-TN): CPEO / MM (Cfrm)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE1171
|
GAC |
Neolithic |
Poland |
M |
-2880 |
-2776 |
J1c3f |
bam
|
2.60
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12477C (MT-ND5): possible HCM susceptibility (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
RISE1172
|
GAC |
Neolithic |
Poland |
F |
-2880 |
-2776 |
HV0a |
bam
|
3.00
|
|
FASTA
Metadata
|
|
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
|
RISE1160
|
GAC |
Neolithic |
Poland |
M |
-2880 |
-2776 |
T2b |
bam
|
1.90
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE1161
|
GAC |
Neolithic |
Poland |
F |
-2880 |
-2776 |
H27+16093 |
bam
|
1.30
|
|
FASTA
Metadata
|
|
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
16129A (MT-CR): Cyclic Vomiting Syndrome with Migraine (Reported)
-
4440A (MT-TM): Mitochondrial myopathy (Reported)
|
RISE1163
|
GAC |
Neolithic |
Poland |
M |
-2880 |
-2776 |
HV0a |
bam
|
3.90
|
|
FASTA
Metadata
|
|
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
-
4440A (MT-TM): Mitochondrial myopathy (Reported)
-
5650A (MT-TA): Myopathy (Cfrm)
|
RISE1164
|
GAC |
Neolithic |
Poland |
F |
-2880 |
-2776 |
K1a1b1e |
bam
|
1.10
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
114T (MT-CR): BD-associated (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE1165
|
GAC |
Neolithic |
Poland |
M |
-2880 |
-2776 |
HV16 |
bam
|
2.10
|
|
FASTA
Metadata
|
|
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
|
RISE1168
|
GAC |
Neolithic |
Poland |
M |
-2880 |
-2776 |
HV0a |
bam
|
2.40
|
|
FASTA
Metadata
|
|
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
|
RISE1169
|
GAC |
Neolithic |
Poland |
M |
-2880 |
-2776 |
HV0a |
bam
|
1.10
|
|
FASTA
Metadata
|
|
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
|
RISE1173
|
GAC |
Neolithic |
Poland |
M |
-2880 |
-2776 |
HV0a |
bam
|
2.90
|
|
FASTA
Metadata
|
|
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
-
4440A (MT-TM): Mitochondrial myopathy (Reported)
|